20.11.2018 | Avoimet työpaikat
https://www.triolab.fi/tyopaikkailmoitus-tuotespesialisti/?fbclid=IwAR1aGmamXI7q_lpHJXi26eK7LAB05QlqIl4qEqIw4L3XYjtitDtGo6E24H4
Triolab Oy hakee tuotespesialistia tutkimustuotteiden myyntiin, markkinointiin sekä tuotetukeen.
Pääasiallisena työtehtävänäsi on jatkuvasti laajentuvan tutkimustuotevalikoimamme tuotteiden myynti, markkinointi ja tuotetuki yliopistoille ja tutkimuslaitoksille koko Suomen alueella. Sinulla on lisäksi merkittävä rooli asiakassuhteiden kehittämisessä ja vahvistamisessa yhteistyössä muun organisaatiomme kanssa. Teet tiivistä yhteistyötä tiimin kokeneempien asiantuntijoidemme kanssa, mutta pääset myös toteuttamaan itseäsi. Emme odota löytävämme valmista kenttätyön osaajaa, vaan innokkaan ja myyntihenkisellä asenteella varustetun tulevaisuuden ammattilaisen! Sinulla on hyvä englannin suullinen ja kirjallinen taito, ruotsin kielen taito katsotaan eduksi. Sinulla on myös valmius matkustaa kotimaassa viikoittain.
Tarjoamme mielenkiintoisen ja haastavan työn reilussa ja mutkattomassa, töitä tosissaan tekevässä organisaatiossa sekä kilpailukykyisen palkkauksen ja työsuhde-edut.
Lähetä hakemuksesi, ansioluettelosi ja palkkatoiveesi sähköpostitse osoitteeseen
jussi.kurittu@triolab.fi.
Lisätietoja Triolab Oy:ssä antaa myyntijohtaja Jussi Kurittu (p. 0400 800 917,
jussi.kurittu@triolab.fi).
19.11.2018 | Avoimet työpaikat
https://city-lab.fi/wp-content/uploads/2018/11/Viikin-ty%C3%B6paikkailmoitus-2018-2.pdf
https://city-lab.fi/toihin-city-labiin/
City-Lab hakee viimeistään 7.1.2019 alkaen
Asiakaspalveluspesialistia
vakituiseen työsuhteeseen Viikin toimipisteeseensä Helsinkiin
- Sinulla on bioalan koulutustausta
- Sinulla on kokemusta ja tietoa molekyylibiologiasta, proteiinikemiasta ja soluviljelystä
- Olet reipas, innostunut, ahkera ja toimeen tarttuva
- Olet omatoiminen ja asiakaspalveluhenkinen
- Olet luotettava, avoin ja positiivinen
- Olet pitkäjänteinen, paneutuva ja asiakkaiden etua ajatteleva
- Tulet toimeen erilaisten ihmisten kanssa, suomeksi ja englanniksi
Katso lisätietoja tästä. Hae viimeistään 30.11.2018.
19.11.2018 | Avoimet työpaikat
A postdoctoral position is available in the lab of Osamu Shimmi at the Institute of Biotechnology, University of Helsinki. We are interested in signaling and epithelial morphogenesis in Drosophila. The aim of the postdoc project is to uncover the molecular mechanisms of cell-cell communications during dynamic processes of Drosophila wing development. The research projects include the fields of Drosophila genetics and advanced light microscopy, and they offer an interdisciplinary environment for research training. Prior knowledge in cell biology and experiences in imaging analysis and/or Drosophila genetics are considered advantageous. We are looking for an individual interested in joining our dynamic and international research community. We are a member of the Center of Excellence for Experimental and Computational Developmental Biology (2014-2019) of the Academy of Finland with a goal to obtain general principles and mechanisms that can be used to explain the development of different organs across different species.
The position is available immediately and will be filled until December 31, 2019 (with a possibility of extension). Further enquiries regarding the scope and details of the projects should be addressed to: osamu.shimmi@helsinki.fi or visit http://www.biocenter.helsinki.fi/bi/shimmi/ .
Applications are to be sent as a single pdf-file by December 15, 2018 by e-mail (Subject: Postdoc application) to osamu.shimmi@helsinki.fi . The document should include a short cover letter describing your expertise areas and motivation for the position, CV (max 2 pages), and names and contact information of at least two references.
Applications are reviewed as they are received, and the position may be filled even before the application deadline if a suitable candidate is identified.
19.11.2018 | Avoimet työpaikat
ENDOWED PROFESSORSHIP IN DRUG ABUSE RESEARCH
Indiana University – Bloomington and The Department of Psychological and Brain Sciences seek an outstanding midcareer drug abuse and addiction researcher to fill the recently established Naus Family Chair in Psychological and Brain Sciences. The Naus Family Chair is funded through a generous gift from David Naus with a goal of improving our understanding of the neurobiology and treatment of drug addiction through fundamental and applied research. This position offers an attractive salary and start-up package, a generous annual endowment, membership in our NIDA training grant, and access to substantial core services as well as state-of-the-art human neuroimaging and animal facilities. We specifically seek a collegial individual with a record of outstanding research contributions in the field of addiction research, proven ability to secure
sustained extramural funding, expertise in state-of-the art techniques, commitment to graduate and undergraduate education, and demonstrated leadership in their chosen field. The Naus Chair will join the vibrant drug abuse research community at Indiana University, which has been further strengthened through a university-wide, 5 year, $50,000,000 “Grand Challenge” initiative which is addressing the addiction crisis at multiple levels.
Applicants should have an advanced degree (a PhD and/or MD) in a relevant discipline. Interested candidates should review the application requirements and submit their application, CV, research statement, teaching statement and three letters of recommendation to: https://indiana.peopleadmin.com/postings/6545.
Review of applications will begin January 7, 2019 and continue until the position is filled. The College of Arts and Sciences is committed to building and supporting a diverse, inclusive, and equitable community of students and scholars.
Questions regarding the position or application process can be directed to: William P. Hetrick, PhD, Professor & Chair, Department of Psychological and Brain Sciences, whetrick@indiana.edu or Ken Mackie, MD search committee chair, kmackie@indiana.edu with “Naus Family Chair” in the subject line.
Indiana University is an equal employment and affirmative action employer and a provider of ADA services. All qualified applicants will receive consideration for employment without regard to age, ethnicity, color, race, religion, sex, sexual orientation, gender identity or expression, genetic information, marital status, national origin, disability status or protected veteran status.
19.11.2018 | Avoimet työpaikat
The Faculty of Medicine at the University of Helsinki conducts high-quality research and provides research-based basic and post-graduate education in medicine and dentistry, psychology and logopedics. The Faculty of Medicine at the University of Helsinki is located in the Meilahti-Ruskeasuo Campus, offering excellent opportunities for close collaboration with both the University Hospital and public sector research institutes.
Research Programs Unit of the Faculty of Medicine is a top-quality research environment. Unit’s five research program comprises groups that integrate clinical, translational and biomedical research. The Clinical and Molecular Metabolism program (starting 2019) brings together the best research in the field of diabetes and obesity in Finland.
Group Pietiläinen’s aim at the Obesity Research Unit is to identify mechanisms behind obesity-related metabolic disturbances and to study their novel treatment options. Her research is especially focused on mitochondrial function in obesity in adipose tissue and muscle, and the group is part of the Center of Excellence for Research on Mitochondria, Metabolism and Disease (FinMIT) http://www.fin-mit.fi/en/ .
Pietiläinen group invites applications for a position of
POSTDOCTORAL RESEARCHER
beginning from 1.1.2019 till 31.12.2019.
The applicant should have
o Doctoral degree
o Strong background in obesity and/or mitochondrial metabolism.
o Background in basic biology, cell cultures, preferably adipocytes and myoblasts, as well as in other laboratory techniques, especially those regarding mitochondria.
o Background in bioinformatics or biostatistics and handling of omics datasets is of special advantage
o Innovative and creative thinking
o Ability to work independently
o Outstanding written and oral English skills
Your application should include a CV, publication list, motivation letter and contact details for referees (referee letters are considered a surplus).
Salary will be based on the Universities salary scheme for teaching and research personnel composed of both task specific (demand level 5) and personal performance components. Trial period will be applied.
Please submit your application using the University of Helsinki Recruitment System via the link Apply for job or directly to Professor Pietiläinen, kirsi.pietilainen@helsinki.fi .
17.11.2018 | Uutiset
Jyväskylän, Nantesin ja Illinoisin yliopiston tutkijoista koostuva kansainvälinen tutkimusryhmä on selvittänyt filamiini-proteiiniin liittyvän mutaation roolia sydämen läppävian synnyssä. Sydämen läppäviasta kärsii noin 3 % maailman väestöstä, ja se yleisin sydänleikkausten syy koska lääkehoitoa ei ole vielä saatavilla. Tutkimus auttaa sairauden syntymekanismien selvittämistä sekä lääkehoidon kehittämistä. Onnea Tatu Haataja ja muut, vaikuttavaa työtä!
Lue uutinen täältä!
15.11.2018 | Uutiset
4.0.4
https://www.hs.fi/paivanlehti/15112018/art-2000005899120.html
Helsingin Sanomissa tänään juttu Todde Fribergin leukemiaan sairastumisesta. Syöpäsäätiö jakaa 7 miljoonaa euroa 99 tutkijalle. Suurapurahan ovat saaneet Merja Heinäniemi Itä-Suomen yliopistosta ja Olli Lohi Tampereen yliopistollisesta sairaalasta. Heidän tutkimuksensa keskittyy genomiikan hyödyntämiseen lasten akuutin lymfaattisen leukemian hoitojen suunnittelusssa. Leukemia on lasten yleisin syöpä, johon sairastuu vuosittain 50 lasta. Tutkimusrahaa tarvitaan kipeästi uusien hoitojen kehittämiseen eri syövissä, sillä syöpään sairastuvien määrä kasvaa jatkuvasti. #Syöpätutkimus #tutkimus #apurahat #syöpäsäätiö
13.11.2018 | Tapahtumat
http://www.kct.fi/kct-seminar-johanna-nystedt-finnish-red-cross-blood-service
KCT is welcoming Johanna Nystedt to talk about The Finnish Red Cross Blood Service: Cell therapies at all levels.
The seminar is taking place at meeting room Mega, Microkatu 1, Technopolis on 21st November at 10-11am.
The event is free of charge and open to anyone who is interested in the subject.
ABSTRACT
The Finnish Red Cross Blood Service (FRCBS), a not-for-profit organization, is the nationwide blood service provider in Finland and our main task is to provide the Finnish hospitals with various blood cell products for treating patients. The FRCBS is also active in the cell therapy field and hosts the Advanced Cell Therapy Centre with its GMP facilities for the development and manufacturing of novel cell therapy products. The presentation will shed light on past and on-going cell therapy programs with specific focus on mesenchymal stromal cells (MSCs) from basic biology, immunomodulatory mechanisms, GMP manufacturing and clinical use.
Participants can send questions they would like to be addressed in the presentation to Johanna Nystedt (johanna.nystedt@bloodservice.fi).
The seminar is organized by Kuopio Center for Gene and Cell Therapy (KCT).
The event, which is free of charge and open to everyone interested, will be held in English. No registration needed. Welcome!
For upcoming KCT seminars, please visit http://www.kct.fi/news
KCT Kuopio Center for Gene and Cell Therapy Oy, Microkatu 1, 70210 Kuopio, Finland
13.11.2018 | Uutiset
https://yle.fi/uutiset/3-10486483?fbclid=IwAR3zxxgTrFX03jfvUWxr8QbR1Pr2EtgDobWDPjh6HFZm-EaRkh_vkNrEZ3I
Yle.fi:n etusivulla Lihastohtori Juha Hulmi, joka on pureutunut uudessa kirjassaan yleisiin liikunta- ja syömisväitteisiin sekä niiden todenmukaisuuteen. Oli suuri kunnia saada Juha Hulmi puhujaksi tieteen popularisointi -seminaariimme vuonna 2016, Hulmin tärkeä työ tieteen popularisoinnissa jatkuu edelleen!
13.11.2018 | Avoimet työpaikat
About the position
A permanent senior scientist position is available at Centre for Molecular Medicine Norway (NCMM), an EMBL partnership institute in Oslo, in the soon to start CRISPR gene therapy group led by Emma Haapaniemi, MD-PhD.
The aim of our laboratory is to build a gene editing platform that can be used to correct patient-specific mutations in ex vivo cell therapies for genetic immune and other rare childhood diseases. We will use high-throughput biology techniques to optimize, develop and understand the CRISPR-Cas system that forms the base of the platform, and develop and implement methods to evaluate its safety in a clinical setting. We will use the modified gene editing technologies for the benefit of the patients in the adjacent children’s hospital.
We look for an experienced scientist who has postdoctoral research experience in multiple research environments. You are detail-oriented and rigorous experimentalist who enjoys working at the bench and performing well-thought, high-quality cell biology experiments. You have a solid basic science training in biochemistry or related field, and can perform standard bioinformatics and computational biology analyses in linux environment.
Work tasks
- Design and optimize custom Next Generation Sequencing libraries
- Design and conduct customized CRISPR screening experiments
- Supervise graduate students, postdoctoral fellows and technicians in designing and conducting molecular biology experiments.
- Perform standard wetlab molecular biology experiments
Qualification requirements
- PhD with postdoctoral research experience
- Documented research experience in one or more of the following fields: High-throughput biology and/or Next Generation Sequencing method development, DNA repair and genome stability, Immunology or stem cell biology
- Fluent oral and written communication skills in English
These qualifications count in the assessment
- Python, Perl, R and other relevant programming language skills
- Advanced statistics skills
- Certification to independently supervise and conduct experiments on mouse models
We offer
- salary NOK 524 200 – 597 400 per annum depending on qualifications in position as Researcher position code 1109
- An exciting, translational project where your strong basic science background can directly benefit our sickest patients
- Opportunity to shape a new laboratory
- The possibility to develop your leadership skills when our team grows
- attractive welfare benefits and a generous pension agreement, in addition to Oslo’s family-friendly environment with its rich opportunities for culture and outdoor activities
Apply here (email applications are not considered):
